RxDoctor Payments DataLook up a doctor →

Wendy Gill

Adult Health · Baton Rouge, LANPI 1821272709

Payments from drug & device makers

$12,542in general payments, 2019–2025

Across 583 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • Novartis$1K
  • AstraZeneca$960
  • Pfizer$856
  • Merck$499
  • Takeda Pharmaceuticals U.S.A., Inc.$490
  • plus $7K from 54 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Johnson & Johnson(2 entities)38$1,227
Novartis66$1,194
AstraZeneca(2 entities)54$960
Pfizer53$856
Merck25$499
Takeda Pharmaceuticals U.S.A., Inc.21$490
Bayer19$425
Incyte Corporation15$402
Amgen18$379
Sanofi16$370
Gilead17$339
Astellas Pharma US Inc13$335
Ipsen Biopharmaceuticals, Inc12$322
Genentech USA, Inc.14$317
Exelixis Inc.15$295
AbbVie13$281
Pharmacyclics LLC, An Abbvie Company10$265
Sanofi-aventis U.S. LLC3$259
E.r. Squibb & Sons, L.L.C.14$259
Bristol Myers Squibb13$241
Daiichi Sankyo Inc.7$230
Seagen Inc.4$207
Beigene USA, Inc.9$184
Eisai Inc.7$143
Sobi, Inc6$134
Karyopharm Therapeutics Inc.7$128
Morphosys, US Inc.8$128
Blueprint Medicines Corporation8$127
Geron Corporation5$116
Pharmacosmos Therapeutics Inc.6$113
Regeneron Healthcare Solutions, Inc.6$109
EMD Serono, Inc.6$102
Stemline Therapeutics Inc.5$102
Myriad Genetic Laboratories, Inc.2$97
Adaptive Biotechnologies Corporation4$96
GSK4$74
Apellis Pharmaceuticals, Inc.4$72
ADC Therapeutics America, Inc.3$64
Lilly USA, LLC4$62
Veracyte, Inc.4$56
AVEO Pharmaceuticals, Inc.2$42
Coherus Oncology, Inc.2$41
Mirati Therapeutics, Inc.2$39
G1 Therapeutics, Inc.2$32
Jazz Pharmaceuticals Inc.1$29
Servier Pharmaceuticals LLC1$25
Sanofi Pasteur Inc.1$22
Boehringer Ingelheim1$22
Immunogen, Inc.1$22
Novocure Inc.1$21
Immunocore Limited1$21
Cumberland Pharmaceuticals, Inc.1$21
Helsinn Therapeutics (U.S.), Inc.1$21
Syndax Pharmaceuticals, Inc.1$19
Alnylam Pharmaceuticals Inc.1$19
Springworks Therapeutics, Inc.1$17
TG Therapeutics, Inc.1$17
Beone Medicines USA, Inc.1$16
Pharmaessentia USA Corporation1$15
Organon1$15

How this compares

$12,542 in reported general payments places this provider in the 95th percentile of 203 adult health providers in Louisiana.

See all adult health providers in Louisiana

Medicare billing

Part B allowed, 2024
$548,090
Medicare patients
202
Services billed
18,620

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other adult health in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →